Omeprazole Evolugen Pharma

Omeprazole, the active ingredient in Omeprazole Evolugen Pharma, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazole Evolugen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole Evolugen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Evolugen Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - Erosive esophagitis: heals erosive damage caused by chronic acid exposure.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased gas production. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reactions. - Liver enzyme elevation: signs of hepatic stress. - Fracture risk: potential decrease in bone mineral density with long‑term use.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Review hepatic status: use with caution in liver disease. - Evaluate for infections: monitor for Clostridioides difficile symptoms. - Long‑term use: assess bone health and magnesium levels periodically. - Pregnancy and lactation: weigh benefits against potential risks. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ketoconazole: decreased absorption due to reduced gastric acidity. - Atazanavir: markedly reduced plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: reduced serum levels. - Digoxin: possible increase in serum concentration.